Corheart 6 VAS Study

See also
	Status	Clinical Trial	Phase
	Completed	`NCT01758627` - The Role of Peritoneal Dialysis in Patients With Refractory Heart Failure and Chronic Kidney Disease	N/A
	Terminated	`NCT01001793` - Levacor™ Ventricular Assist Device (VAD) Bridge to Transplant Study	N/A

See also

Status

Clinical Trial

Phase

Completed

NCT01758627 - The Role of Peritoneal Dialysis in Patients With Refractory Heart Failure and Chronic Kidney Disease

N/A

Terminated

NCT01001793 - Levacor™ Ventricular Assist Device (VAD) Bridge to Transplant Study

N/A

Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.

Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.

Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

NCT number	NCT05876000
Study type	Interventional
Source	Shenzhen Core Medical Technology CO.,LTD.
Contact	Xiaoli Shi
Phone	+86 13418601356
Email	shixiaoli@coretechmed.com
Status	Not yet recruiting
Phase	N/A
Start date	September 2023
Completion date	December 2029

Corheart 6 VAS Study

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms